These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 582089)

  • 21. Gamma-glutamyltranspeptidase and alkaline phosphatase serum activities: their relation to the outcome of Graves' disease.
    Benvenga S; Melluso R; Vermiglio F; Trimarchi F
    Enzyme; 1985; 34(2):64-70. PubMed ID: 2867896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum alkaline phosphatase isoenzyme studies during thyreostatic therapy using 1-methyl-2-mercaptoimidazole].
    Vormittag W; Vormittag E; Höfer R
    Wien Klin Wochenschr; 1972 Dec; 84(48):774-8. PubMed ID: 4641137
    [No Abstract]   [Full Text] [Related]  

  • 23. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum alkaline phosphatase isoenzyme patterns in patients with chronic renal failure.
    Skillen AW; Pierides AM
    Clin Chim Acta; 1977 Oct; 80(2):339-46. PubMed ID: 912906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictor of outcome of hyperthyroidism due to Graves disease: serum triiodothyronine/thyroxine ratio.
    Khanna CM; Shankar LR; Jaggi CB; Bansal JK; Chugh P
    J Assoc Physicians India; 1996 Feb; 44(2):98-101. PubMed ID: 10999059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.
    Kojima N; Sakata S; Nakamura S; Nagai K; Takuno H; Ogawa T; Matsui I; Sarui H; Miura K
    J Endocrinol Invest; 1992; 15(7):491-6. PubMed ID: 1447487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkaline phosphatase isoenzymes in plasma in hyperthyroidism.
    Tibi L; Patrick AW; Leslie P; Toft AD; Smith AF
    Clin Chem; 1989 Jul; 35(7):1427-30. PubMed ID: 2758588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperthyroidism in Patients with Graves' Ophthalmopathy, and Thyroidal, Skeletal and Eye Muscle Specific Type 2 Deiodinase Enzyme Activities.
    Molnár I; Szentmiklósi JA; Somogyiné-Vári É
    Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):514-521. PubMed ID: 28750432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term treatment of Graves' hyperthyroidism with sodium ipodate.
    Shen DC; Wu SY; Chopra IJ; Huang HW; Shian LR; Bian TY; Jeng CY; Solomon DH
    J Clin Endocrinol Metab; 1985 Oct; 61(4):723-7. PubMed ID: 3928675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease.
    Takamatsu J; Takeda K; Katayama S; Sakane S; Morita S; Kuma K; Ohsawa N
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1145-50. PubMed ID: 1400885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute effects of corticosteroids on thyroid activity in Graves' disease.
    Williams DE; Chopra IJ; Orgiazzi J; Solomon DH
    J Clin Endocrinol Metab; 1975 Aug; 41(2):354-61. PubMed ID: 1174132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The isoenzyme pattern of serum alkaline phosphatase in patients on intermittent haemodialysis and kidney transplant recipients (author's transl)].
    Bayer PM; Zazgornik J; Schmidt P; Bratusch-Marrein P; Gabl F
    Wien Klin Wochenschr; 1975 Oct; 87(19):646-8. PubMed ID: 775797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophoretic studies on alkaline phosphatases in normal and zinc intoxicated rats.
    Thawley DG; Willoughby RA
    Can J Comp Med; 1977 Jan; 41(1):84-8. PubMed ID: 832193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.
    Takamatsu J; Sugawara M; Kuma K; Kobayashi A; Matsuzuka F; Mozai T; Hershman JM
    Ann Intern Med; 1984 Mar; 100(3):372-5. PubMed ID: 6546484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further studies on the long-term treatment of Graves' hyperthyroidism with ipodate: assessment of a minimal effective dose.
    Shen DC; Wu SY; Chopra IJ; Shian LR; Florsheim W; Solomon DH
    Thyroid; 1991; 1(2):143-6. PubMed ID: 1822359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue sources of elevated serum alkaline phosphatase activity in hyperthyroid patients.
    Rhone DP; Berlinger FG; White FM
    Am J Clin Pathol; 1980 Oct; 74(4):381-6. PubMed ID: 6107041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
    Chopra IJ; Williams DE; Orgiazzi J; Solomon DH
    J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
    Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.